TEL: 616.808.2695 | FAX: 616.808.2697
1959 EAST PARIS AVE SE, GRAND RAPIDS, MI 49546
Tesamorelin Peptide
Tesamorelin Peptide
Tesamorelin is a synthetic peptide that acts as a growth hormone–releasing hormone (GHRH) analog. It stimulates the pituitary gland to increase production and release of growth hormone, which can subsequently increase insulin-like growth factor-1 (IGF-1).
Tesamorelin is best known medically for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is FDA-approved for that specific indication, not as a general weight-loss medication.
How tesamorelin works
Tesamorelin mimics GHRH, signaling the pituitary to release more of the body's own growth hormone. Increased growth hormone can affect:
-
Visceral abdominal fat
-
Body composition
-
Fat metabolism
-
IGF-1 levels
-
Certain aspects of metabolic function
Tesamorelin vs. HGH
Tesamorelin does not directly provide growth hormone. Instead, it stimulates the body's natural growth-hormone production. This differs from HGH (somatropin), which is recombinant human growth hormone administered directly.
Tesamorelin Benefits
-
Visceral Fat Reduction: Targets deep belly fat that surrounds internal organs, which helps lower cardiometabolic health risks.
-
Lean Muscle Preservation: Supports the body in maintaining or building lean muscle mass while breaking down fat stores.
-
Improved Lipid Profiles: Can help lower triglyceride levels and improve overall metabolic health markers.
-
Reduced Liver Fat: Studied and utilized for lowering liver fat accumulation in specific populations, such as those with nonalcoholic fatty liver disease (NAFLD).
-
Cognitive and Recovery Support: May improve executive function and memory, alongside supporting general physical recovery and sleep quality via natural growth hormone pulsing.
-
Improved Quality of Sleep
_JPG.jpg)



Tesamorelin Administration
Tesamorelin Dosing
-
Dosing (20mg): 1.0mg injection / 1 x daily before bed / 5 days on 2 off /Subcutaneous injection / 4 Weeks
Recommended Cycle Duration:
-
3 Months On Cycle / 2 Months Off Cycle
Disclaimer:
Individual results vary. Best results obtained with combination of a healthy diet and lifestyle . These products nor the ingredients have been approved or endorsed by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. Homeopathic products have not been reviewed by the FDA for safety and effectiveness to diagnose, treat, cure, or prevent any disease or conditions. These are compounded by a US compounding pharmacy that provides these for physician prescribed patient-specific use only. You should consult a licensed health care professional before starting any peptide, supplement, dietary, or exercise program. Products not recommended if you are pregnant or breast feeding.

Let us help you identify the Peptide treatment that best aligns with your Health & Wellness goals.
Schedule your FREE Peptide consultation
Tesamorelin Peptide Therapy FAQ
1. What is Tesamorelin?
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and release the body's own growth hormone. Increased growth hormone can subsequently increase IGF-1 and influence fat metabolism.
2. What are the benefits of Tesamorelin?
Tesamorelin's best-established benefit is reducing visceral abdominal fat in adults with HIV-associated lipodystrophy. Because Tesamorelin stimulates growth hormone production, it is also being studied for its effects on body composition and metabolic health. Its FDA-approved indication is specifically the reduction of excess abdominal fat associated with HIV lipodystrophy.
3. How does Tesamorelin work?
Tesamorelin mimics GHRH and activates receptors in the pituitary gland, stimulating the body's natural production and release of growth hormone. Growth hormone then stimulates production of insulin-like growth factor-1 (IGF-1), which plays an important role in metabolism and body composition.
4. Does Tesamorelin help reduce belly fat?
Tesamorelin has been shown to reduce visceral abdominal fat, particularly in adults with HIV-associated lipodystrophy. It is important to distinguish visceral-fat reduction from general weight loss: the FDA-approved prescribing information specifically states that Tesamorelin is not indicated for weight-loss management and is labeled as off-label for that purpose.
5. Is Tesamorelin a form of HGH?
No. Tesamorelin is not human growth hormone (HGH). Tesamorelin stimulates the pituitary gland to release the body's own growth hormone, whereas HGH therapy provides recombinant growth hormone directly.
6. What is the difference between Tesamorelin and Sermorelin?
Both Tesamorelin and Sermorelin are GHRH-related peptides that stimulate the body's natural growth hormone production. They are different compounds, however, with different structures, clinical indications, regulatory status, and supporting evidence. Tesamorelin is FDA-approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy, whereas Sermorelin does not have the same FDA-approved indication.
7. What are the side effects of Tesamorelin?
Potential side effects include injection-site reactions, joint or muscle pain, swelling or fluid retention, numbness or tingling, and changes in blood glucose. Tesamorelin can also increase IGF-1 levels and may cause hypersensitivity reactions. Appropriate medical monitoring is important.
8. Is Tesamorelin safe?
Tesamorelin can be prescribed under appropriate medical supervision, but it is not appropriate for everyone. Important considerations include elevated IGF-1, glucose intolerance or diabetes, fluid retention, active malignancy, pregnancy, and hypersensitivity. Tesamorelin should only be used under guidance and prescription of a medicial professional.
9. How is Tesamorelin administered?
Tesamorelin is administered as a subcutaneous injection before bed, generally into the abdominal area. Dosage and administration will be determined by Age Management of West Michigan medical provider.
10. Tesamorelin FDA approved?
Yes. Tesamorelin is FDA-approved for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. Usage for weight loss is off-label. The FDA labeling specifically states that it is not indicated for weight-loss management. Other uses should not be represented as FDA-approved indications.
11. Who may benefit from Tesamorelin?
Tesamorelin may be of interest to adults seeking to decrease visceral body fat in the abdominal region and fat around the liver.
12. Where can I get Tesamorelin peptide therapy in Grand Rapids, MI?
Age Management of West Michigan provides physician-guided peptide therapy in Grand Rapids, Michigan. Tesamorelin may be considered as part of an individualized approach to reducing visceral body fat and healthy aging. A consultation can help determine whether Tesamorelin is appropriate based on your goals and medical history.
13. How do I get started with Tesamorelin peptide therapy?
The first step is a FREE Peptide consultation with a qualified medical professional at Age Management of West Michigan to discuss your goals, medical history, current medications and whether Tesamorelin is an appropriate option. Then an appointment for physician clearance is scheduled and individualized peptide protocol will be prescribed.
